Peregrine Pharmaceuticals is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies focused on the treatment and diagnosis of cancer. PPHM is pursuing multiple clinical programs in the field of oncology with its lead product candidate bavituximab and novel brain cancer agent Cotara®. The company also has in-house cGMP manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. For more information, visit the company’s Web site: http://www.peregrineinc.com
Let us hear your thoughts below: